FO
FOXOW
FOXO TECHNOLOGIES INC.
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
May 28, 2026
SEC
FOXO Technologies entered into a Strategic Technology License Agreement with its founder, Jon R. Sabes, and his entity L
8-K — Impact 4/10
May 22, 2026
SEC
FOXO Technologies settled outstanding obligations with J.H. Darbie by issuing 400 shares of Series D Convertible Preferr
8-K — Impact 6/10
May 18, 2026
SEC
FOXO Technologies exchanged all outstanding Series A Convertible Preferred Stock held by two institutional investors (Sa
8-K — Impact 6/10
Latest Reports
NEUTRAL
8-K
4/10
FOXO Technologies entered into a Strategic Technology License Agreement with its founder, Jon R. Sabes, and his entity L
May 28, 2026
BEARISH
8-K
6/10
FOXO Technologies settled outstanding obligations with J.H. Darbie by issuing 400 shares of Series D Convertible Preferr
May 22, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 1 mixed, 1 neutral. Avg impact: 5.3/10.
NEUTRAL
8-K
4/10
FOXO Technologies entered into a Strategic Technology License Agreement with its founder, Jon R. Sab
May 28, 2026
BEARISH
8-K
6/10
FOXO Technologies settled outstanding obligations with J.H. Darbie by issuing 400 shares of Series D
May 22, 2026
MIXED
8-K
6/10
FOXO Technologies exchanged all outstanding Series A Convertible Preferred Stock held by two institu
May 18, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.